Literature DB >> 7718410

Mechanisms of ATP-induced Ca2+ signaling in osteoclasts.

H Yu1, J Ferrier.   

Abstract

We investigate the mechanisms underlying the intracellular calcium pulse that occurs in response to extracellular adenosine triphosphate (ATP) in osteoclasts. We find that pre-loading of GDP-beta-S abolishes the response in Ca(2+)-free medium, demonstrating an internal release of Ca2+ via a pathway that involves a G protein. GDP-beta-S does not block in normal Ca(2+)-containing medium, suggesting that ATP also induces a Ca2+ influx across the cell membrane. We confirmed this using the Mn2+ quenching technique, which shows significant opening of Ca2+ channels. We find a smaller response to adenosine diphosphate (ADP) and 2-methylthio-ATP (2-MeSATP), but no response to beta, gamma-methylene-ATP (AMP-PCP), adenosine monophosphate (AMP) or uridine triphosphate (UTP). Prior application of AMP and UTP, but not AMP-PCP, blocks the response to ATP. Our results indicate that the receptor is a P2 subtype that is not characteristic of any previously reported P2 receptor or combination of P2 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7718410     DOI: 10.1016/0898-6568(94)90023-x

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

1.  Purinergic signaling is required for fluid shear stress-induced NF-κB translocation in osteoblasts.

Authors:  Damian C Genetos; Norman J Karin; Derik J Geist; Henry J Donahue; Randall L Duncan
Journal:  Exp Cell Res       Date:  2011-01-13       Impact factor: 3.905

2.  ATP is a potent stimulator of the activation and formation of rodent osteoclasts.

Authors:  M S Morrison; L Turin; B F King; G Burnstock; T R Arnett
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

3.  P2 receptors in macrophage fusion and osteoclast formation.

Authors:  Thomas H Steinberg; Jeffrey F Hiken
Journal:  Purinergic Signal       Date:  2007-02-06       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.